METABOLIC ASPECTS OF THE TREATMENT OF HYPERTENSION

被引:11
作者
LITHELL, H
机构
[1] Uppsala University, Uppsala
关键词
HYPERINSULINEMIA; INSULIN RESISTANCE; HYPERTENSION; VASODILATION; BETA-BLOCKADE; ALPHA(1)-BLOCKADE;
D O I
10.1097/00004872-199508001-00012
中图分类号
R6 [外科学];
学科分类号
1002 ; 100210 ;
摘要
Insulin resistance and hypertension: Hypertension is often associated with insulin resistance, which may be the underlying cause of hypertension in many cases. The whole complex of insulin resistance and its related factors appears to be based on a reduction in nutritional blood flow to large muscle groups. Effect of treatment: Blood flow is further reduced during beta-blockade but improves during alpha(1)-blockade, which may explain the contrasting effects of these treatments on insulin resistance and triglyceride metabolism.
引用
收藏
页码:S77 / S80
页数:4
相关论文
共 29 条
[1]  
ANDERSSON PE, 1994, J HUM HYPERTENS, V8, P219
[2]  
AUSTIN MA, 1988, JAMA-J AM MED ASSOC, V260, P1917
[3]  
BERGLUND G, 1976, ACTA MED SCAND, V200, P163
[4]   INSULIN RESISTANCE - A MULTIFACETED SYNDROME RESPONSIBLE FOR NIDDM, OBESITY, HYPERTENSION, DYSLIPIDEMIA, AND ATHEROSCLEROTIC CARDIOVASCULAR-DISEASE [J].
DEFRONZO, RA ;
FERRANNINI, E .
DIABETES CARE, 1991, 14 (03) :173-194
[5]   LDL SUBCLASS PHENOTYPES AND TRIGLYCERIDE-METABOLISM IN NON-INSULIN-DEPENDENT DIABETES [J].
FEINGOLD, KR ;
GRUNFELD, C ;
PANG, MY ;
DOERRLER, W ;
KRAUSS, RM .
ARTERIOSCLEROSIS AND THROMBOSIS, 1992, 12 (12) :1496-1502
[6]   INSULIN RESISTANCE IN ESSENTIAL-HYPERTENSION [J].
FERRANNINI, E ;
BUZZIGOLI, G ;
BONADONNA, R ;
GIORICO, MA ;
OLEGGINI, M ;
GRAZIADEI, L ;
PEDRINELLI, R ;
BRANDI, L ;
BEVILACQUA, S .
NEW ENGLAND JOURNAL OF MEDICINE, 1987, 317 (06) :350-357
[7]   TREATMENT WITH A BETA-BLOCKER WITH BETA(2)-AGONISM IMPROVES GLUCOSE AND LIPID-METABOLISM IN ESSENTIAL-HYPERTENSION [J].
HAENNI, A ;
LITHELL, H .
METABOLISM-CLINICAL AND EXPERIMENTAL, 1994, 43 (04) :455-461
[8]   DECREASED EFFECT OF INSULIN TO STIMULATE SKELETAL-MUSCLE BLOOD-FLOW IN OBESE MAN - A NOVEL MECHANISM FOR INSULIN RESISTANCE [J].
LAAKSO, M ;
EDELMAN, SV ;
BRECHTEL, G ;
BARON, AD .
JOURNAL OF CLINICAL INVESTIGATION, 1990, 85 (06) :1844-1852
[9]   ELEVATED FIBRINOGEN AND PLASMINOGEN-ACTIVATOR INHIBITOR (PAI-1) IN HYPERTENSION ARE RELATED TO METABOLIC RISK-FACTORS FOR CARDIOVASCULAR-DISEASE [J].
LANDIN, K ;
TENGBORN, L ;
SMITH, U .
JOURNAL OF INTERNAL MEDICINE, 1990, 227 (04) :273-278
[10]   METABOLIC EFFECTS OF ISRADIPINE AS MONOTHERAPY OR IN COMBINATION WITH PINDOLOL DURING LONG-TERM ANTIHYPERTENSIVE TREATMENT [J].
LIND, L ;
BERNE, C ;
POLLARE, T ;
LITHELL, H .
JOURNAL OF INTERNAL MEDICINE, 1994, 236 (01) :37-42